Literature DB >> 3066478

Genetic analysis of human malignancy using somatic cell hybrids and monochromosome transfer.

E J Stanbridge1.   

Abstract

Evidence is presented for the existence of genes which regulate the malignant behaviour of human cancer cells. Observations obtained from somatic cell hybrid and monochromosome transfer studies suggest that recessive genes play an important part in the control of malignant expression. Loss of restriction fragment length polymorphism alleles, consistent with loss of these putative tumour-suppressor genes, is associated with an increasing number of human cancers.

Entities:  

Mesh:

Year:  1988        PMID: 3066478

Source DB:  PubMed          Journal:  Cancer Surv        ISSN: 0261-2429


  5 in total

1.  Interference with energy metabolism by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside induces HPV suppression in cervical carcinoma cells and apoptosis in the absence of LKB1.

Authors:  Julia Nafz; Johanna De-Castro Arce; Verena Fleig; Andrea Patzelt; Sybille Mazurek; Frank Rösl
Journal:  Biochem J       Date:  2007-05-01       Impact factor: 3.857

2.  Tumor suppression involves down-regulation of interleukin 3 expression in hybrids between autocrine mastocytoma and interleukin 3-dependent parental mast cells.

Authors:  I D Diamantis; A P Nair; H H Hirsch; C Moroni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Regulation of MCP-1 chemokine transcription by p53.

Authors:  Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Journal:  Mol Cancer       Date:  2010-04-20       Impact factor: 27.401

Review 4.  Lessons learned from studies on tumor suppression by microcell-mediated chromosome transfer.

Authors:  M Oshimura
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

Review 5.  Tumor-suppressor genes: cardinal factors in inherited predisposition to human cancers.

Authors:  H J Evans; J Prosser
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.